[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018

June 2014 | 245 pages | ID: N177A64B4F0EN
MarketsandMarkets

US$ 3,955.00 US$ 5,650.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The North American interventional cardiology and peripheral vascular devices market is expected to grow at a CAGR of 2.9% from 2013 to 2018. Both, the lower volume of coronary angioplasty procedures and the increasing prevalence rate of peripheral artery diseases have impacted the market significantly.

Amongst all the product segments, bioabsorbable stents, retrievable inferior vena cava filters, and diagnostic catheters (intravascular ultrasound and optical coherence tomography catheters) markets are identified as the high growth segments in the North American interventional cardiology and peripheral vascular devices market. Better diagnosis of thrombus using IVUS and OCT catheters is expected to drive the diagnostic catheters market; whereas, lesser risk of long-term post surgical complications in DVT/PE treatments will encourage faster adoption of the retrievable inferior vena cava filters in the coming years. The bioabsorbable stents are still not available for clinical usage in the U.S. However, bioabsorbable stents are available on a special access basis by Health Canada.

The usage factors of different surgical instruments were the major hindrances while deriving the market size of the corresponding surgical devices. This is primarily due to the availability of various surgical instruments for the treatment of similar cardiac ailments. For instance, coronary angioplasty can be performed through plain balloon catheter, stent, and/or a combination of stent and catheter, based on patients’ cardiac health.

The study on the North American interventional cardiology and peripheral vascular devices market captures an exhaustive list of surgical devices which are used in various types of angioplasty procedures, deep vein thrombosis, endovascular aneurysm repairing, and chronic total occlusion (CTO) treatment procedures. This research illustrates specific driving and restraining factors in the U.S. and Canadian markets; furthermore, it identifies the high-growth regions with regard to the interventional cardiology and peripheral vascular devices market. This extensive study provides an analytical comparison of the key players in terms of their segmental revenue and related portfolio and their respective market shares in the U.S. and Canadian market spaces in 2013. In a nutshell, this research intends to capture all facets of the North American interventional cardiology and peripheral vascular devices market to put forward approachable market solutions for leading players as well as new entrants.
1 INTRODUCTION

1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
  1.6.1 Market Size Estimation
  1.6.2 Key Data Points From Primary Sources
  1.6.3 Key Data From Secondary Sources
  1.6.4 Market Share Analysis
  1.6.5 Assumptions

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

3.1 U.S. & Canadian Interventional Cardiology & Peripheral Vascular Devices Market
3.2 Market Dynamics
3.3 North American Interventional Cardiology Devices Market, By Product Type
3.4 Angioplasty Stents & Catheters Market
3.5 Market Share Analysis

4 MARKET OVERVIEW

4.1 North American Demographics
4.2 Interventional Procedures
  4.2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA)
  4.2.2 Percutaneous Transluminal Angioplasty (PTA)
  4.2.3 Endovascular Aneurysm Repair (EVAR) Stent Graft
  4.2.4 Thromboembolism
4.3 Market Segmentation
4.4 Market Dynamics
  4.4.1 Drivers
    4.4.1.1 Increasing Peripheral Interventional Procedures to Drive the Market
    4.4.1.2 Double-Digit Growth in Aging Population to Spur the Market Growth
    4.4.1.3 Significant Increase in Pci Centers in the U.S. and Long Waiting Periods For Care in Canada Encourage Patients to Opt For Mis Procedures
    4.4.1.4 New Cpt Codes to Boost Complex Stenting Procedures
  4.4.2 Restraints & Threats
    4.4.2.1 Declining Coronary Angioplasty Procedures in the U.S. to Restrict Technology Adoption
    4.4.2.2 Conventional First-Level Medication Treatments to Limit the Market Scope
  4.4.3 Opportunities
    4.4.3.1 Rising Importance of Better Diagnosis Will Lead to Increase in Adoption of IVUS and OCT Catheters
    4.4.3.2 Retrievable IVC Filters Market to Witness the Highest Cagr in Pad Treatment Devices Market
    4.4.3.3 Bioabsorbable Stents—A Promising Future For the North American Interventional Cardiology Market
4.5 Market Share Analysis

5 ANGIOPLASTY BALLOONS

5.1 Introduction
5.2 Old/Normal Balloons
  5.2.1 Increasing Adoption of New Technologies Impedes Adoption Rate
5.3 Cutting Balloons
5.4 Scoring Balloons
5.5 Drug-Eluting Balloons

6 ANGIOPLASTY STENTS

6.1 Introduction
  6.1.1 Introduction of Self-Expandable Stents in 2012 in Canada
6.2 Drug-Eluting Stents
  6.2.1 Drug-Eluting Stents to Witness A Sluggish Growth
6.3 Bare-Metal Stents
  6.3.1 Bare-Metal Stents to Show Sluggish Growth Owing to Severe Side-Effects
6.4 Bioabsorbable Stents
  6.4.1 Fewer Post-Surgical Side-Effects to Encourage Faster Adoption

7 CATHETERS MARKET

7.1 Introduction
7.2 Guiding Catheters
7.3 Angiography Catheters
7.4 Intravascular Ultrasound (IVUS) Catheters
7.5 Optical Coherence tomography (OCT) Catheters
  7.5.1 Adoption of OCT Catheters to Help in Easy Diagnosis of Calcified Lesions

8 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET

8.1 Introduction
8.2 Abdominal Aortic Aneurysm (AAA) Stent Grafts
8.3 Thoracic Aortic Aneurysm (TAA) Stent Grafts

9 INFERIOR VENA CAVA (IVC) FILTERS MARKET

9.1 Introduction
9.2 Retrievable Inferior Vena Cava Filters
9.3 Permanent Inferior Vena Cava Filters

10 PLAQUE MODIFICATION DEVICES MARKET

10.1 Introduction
10.2 Thrombectomy Devices
10.3 Atherectomy Devices

11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET

11.1 Introduction
11.2 Embolic Protection Devices (EPD)
11.3 Chronic Total Occlusion (CTO) Devices

12 ACCESSORY DEVICES MARKET

12.1 Introduction
12.2 Vascular Closure Devices
12.3 Introducer Sheaths
12.4 Guide Wires
12.5 Balloon Inflation Devices

13 GEOGRAPHIC ANALYSIS

13.1 Introduction
  13.1.1 U.S.
    13.1.1.1 Over 20% Growth in Pci Facilities to Drive Technology Adoption
    13.1.1.2 Consistent Growth in Peripheral Intervention Procedures Drive the Market Momentum
    13.1.1.3 Lower Volume of Pci Procedures Remains A Major Concern
    13.1.1.4 Stringent Regulations to Restrict Market Growth
  13.1.2 Canada
    13.1.2.1 Lesser Risk of Restenosis to Drive the Future Market Momentum
    13.1.2.2 Poor Infrastructure to Hinder the Adoption of Interventional Cardiology Technologies
    13.1.2.3 Growth in Aging Population and Lifestyle Diseases to Propel the Interventional Cardiology Market

14 COMPETITIVE LANDSCAPE

14.1 Introduction
14.2 New Product Launches
14.3 Mergers & Acquisitions
14.4 Agreements, Partnerships, Collaborations, Contracts, and Joint Ventures
14.5 Other Developments

15 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)

15.1 Abbott Laboratories
15.2 B. Braun Melsungen AG
15.3 Biotronik SE & Co. Kg
15.4 Boston Scientific Corporation
15.5 Cook Medical, Inc.
15.6 Cordis Corporation
15.7 Covidien Plc
15.8 C. R. Bard, Inc.
15.9 W.L.Gore & Associates, Inc.
15.1 Medtronic Inc. (Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.)

LIST OF TABLES

Table 1 North America: Peripheral Vascular Devices Market Size (Value), By Product, 2011–2018 ($Million)
Table 2 North America: Peripheral Vascular Devices Revenue Market Matrix
Table 3 North America: Interventional Cardiology Devices Market Size (Value), U.S. VS. Canada ($Million), 2011–2018
Table 4 North American Demographics, 2013
Table 5 North America: Angioplasty Balloons Market Size (Volume), By Type, 2011–2018 (Thousand Units)
Table 6 North America: Angioplasty Balloons Market Size (Value), By Type, 2011–2018 ($Million)
Table 7 North America: Old/Normal Angioplasty Balloon Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 8 North America: Old/Normal Angioplasty Balloons Market Size (Value), By Country, 2011–2018 ($Million)
Table 9 North America: Angioplasty Cutting Balloons Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 10 North America: Angioplasty Cutting Balloons Market Size (Value), By Country, 2011–2018 ($Million)
Table 11 North America: Angioplasty Stents Market Size (Volume), By Type, 2011–2018 (Thousand Units)
Table 12 North America: Angioplasty Stents Market Size (Value), By Type, 2011–2018 ($Million)
Table 13 North America: Drug-Eluting Stents Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 14 North America: Drug-Eluting Stents Market Size (Value), By Country, 2011–2018 ($Million)
Table 15 North America: Bare-Metal Stents Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 16 North America: Bare-Metal Stents Market Size (Value), By Country, 2011–2018 ($Million)
Table 17 North America: Bioabsorbable Stents Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 18 North America: Bioabsorbable Stents Market Size (Value), By Country, 2011–2018 ($Million)
Table 19 North America: Vascular Catheters Market Size (Volume), By Type, 2011–2018 (Thousand Units)
Table 20 North America: Vascular Catheters Market Size (Value), By Type, 2011–2018 ($Million)
Table 21 North America: Guiding Catheters Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 22 North America: Guiding Catheters Market Size (Value), By Country, 2011–2018 ($Million)
Table 23 North America: Angiography Catheters Market Size (Volume),By Country, 2011–2018 (Thousand Units)
Table 24 North America: Angiography Catheters Market Size (Value), By Country, 2011–2018 ($Million)
Table 25 North America: Intravascular Ultrasound Catheters Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 26 North America: Intravascular Ultrasound Catheters Market Size (Value), By Country, 2011–2018 ($Million)
Table 27 North America: Optical Coherence Tomography Catheters Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 28 North America: Optical Coherence Tomography Catheters Market Size (Value), By Country, 2011–2018 ($Million)
Table 29 North America: EVAR Stent Grafts Market Size (Volume), By Type, 2011–2018 (Thousand Units)
Table 30 North America: EVAR Stent Grafts Market Size (Value), By Type, 2011–2018 ($Million)
Table 31 North America: Abdominal Aortic Aneurysm Stent Grafts Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 32 North America: Abdominal Aortic Aneurysm Stent Grafts Market Size (Value), By Country, 2011–2018, ($Million)
Table 33 North America: Thoracic Aortic Aneurysm Stent Grafts Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 34 North America: Thoracic Aortic Aneurysm Stent Grafts Market Size (Value), By Country, 2011–2018 ($Million)
Table 35 North America: Inferior Vena Cava Filters Market Size (Volume), By Type, 2011–2018 (Thousand Units)
Table 36 North America: Inferior Vena Cava Filters Market Size (Value), By Type, 2011–2018 ($Million)
Table 37 North America: Retrievable Inferior Vena Cava Filters Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 38 North America: Retrievable Inferior Vena Cava Filters Market Size (Value), By Country, 2011–2018 ($Million)
Table 39 North America: Permanent Inferior Vena Cava Filters Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 40 North America: Permanent Inferior Vena Cava Filters Market Size (Value), By Country, 2011–2018 ($Million)
Table 41 North America: Plaque Modification Devices Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 42 North America: Plaque Modification Devices Market Size (Value), By Country, 2011–2018 ($Million)
Table 43 North America: Thrombectomy Devices Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 44 North America: Thrombectomy Devices Marketsize (Value), By Country, 2011–2018 ($Million)
Table 45 North America: Atherectomy Devices Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 46 North America: Atherectomy Devices Market Size (Value), By Country, 2011–2018 ($Million)
Table 47 North America: Hemodynamic Flow Alteration Devices Market Size (Volume), By Type, 2011–2018 (Thousand Units)
Table 48 North America: Hemodynamic Flow Alteration Devices Market Size (Value), By Type, 2011–2018 ($Million)
Table 49 North America: Embolic Protection Devices Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 50 North America: Embolic Protection Device Market Size (Value), By Country, 2011–2018 ($Million)
Table 51 North America: Chronic Total Occlusion Devices Market Size (Volume), By Country, 2011–2018 (Thousand Units)
Table 52 North America: Chronic Total Occlusion Devices Market Size (Value), By Country, 2011–2018 ($Million)
Table 53 North America: Accessory Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 54 North America: Accessory Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 55 North America: Vascular Closure Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 56 North America: Vascular Closure Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 57 North America: Introducer Sheaths Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 58 North America: Introducer Sheaths Market Size (Value), By Type, 2011-2018 ($Million)
Table 59 North America: Guide Wires Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 60 North America: Guide Wires Market Size (Value), By Type, 2011-2018 ($Million)
Table 61 North America: Balloon Inflation Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 62 North America: Balloon Inflation Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 63 North America: Peripheral Vascular Devices Market Size (Value), By Product Segment, 2011–2018 ($Million)
Table 64 U.S.: Peripheral Vascular Devices Market Size (Value), By Product, 2011–2018 ($Million)
Table 65 U.S.: Angioplasty Balloons Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 66 U.S.: Angioplasty Balloons Market Size (Value), By Type, 2011-2018 ($Million)
Table 67 U.S.: Angioplasty Stents Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 68 U.S.: Angioplasty Stents Market Size (Value), By Type, 2011-2018 ($Million)
Table 69 U.S.: Vascular Catheters Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 70 U.S.: Vascular Catheters Market Size (Value), By Type, 2011-2018 ($Million)
Table 71 U.S.: EVAR Stent Grafts Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 72 U.S.: EVAR Stent Grafts Market Size (Value), By Type, 2011-2018 ($Million)
Table 73 U.S.: Inferior Vena Cava Filters Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 74 U.S.: Inferior Vena Cava Filters Market Size (Value), By Type, 2011-2018 ($Million)
Table 75 U.S.: Plaque Modification Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 76 U.S.: Plaque Modification Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 77 U.S.: Hemodynamic Flow Alteration Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 78 U.S.: Hemodynamic Flow Alteration Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 79 U.S.: Accessory Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 80 U.S.: Accessory Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 81 Canada: Peripheral Vascular Devices Market Size (Value), By Product, 2011–2018 ($Million)
Table 82 Canada: Angioplasty Balloons Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 83 Canada: Angioplasty Balloons Market Size (Value), By Type, 2011-2018 ($Million)
Table 84 Canada: Angioplasty Stents Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 85 Canada: Angioplasty Stents Market Size (Value), By Type, 2011-2018 ($Million)
Table 86 Canada: Vascular Catheters Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 87 Canada: Vascular Catheters Market Size (Value), By Type, 2011-2018 ($Million)
Table 88 Canada: EVAR Stent Grafts Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 89 Canada: EVAR Stent Grafts Market Size (Value), By Type, 2011-2018 ($Million)
Table 90 Canada: Inferior Vena Cava Filters Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 91 Canada: Inferior Vena Cava Filters Market Size (Value), By Type, 2011-2018 ($Million)
Table 92 Canada: Plaque Modification Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 93 Canada: Plaque Modification Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 94 Canada: Hemodynamic Flow Alteration Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 95 Canada: Hemodynamic Flow Alteration Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 96 Canada: Accessory Devices Market Size (Volume), By Type, 2011-2018 (Thousand Units)
Table 97 Canada: Accessory Devices Market Size (Value), By Type, 2011-2018 ($Million)
Table 98 New Product Launches, 2011–2014
Table 99 Mergers and Acquisitions, 2011–2014
Table 100 Agreements, Partnerships, Collaborations, Contracts, and Joint Ventures, 2011–2014
Table 101 Other Developments, 2011–2014
Table 102 Abbott Laboratories: Total Revenue, By Segment, 2011–2013 ($Million)
Table 103 B. Braun Melsungen AG: Total Revenue, By Segment, 2011–2013 ($Million)
Table 104 Boston Scientific Corporation: Total Revenue, By Segment, 2011–2013 ($Million)
Table 105 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Segment, 2011–2013 ($Million)
Table 106 Covedien, Plc: Total Revenue, By Segment, 2011–2013 ($Million)
Table 107 C.R.Bard, Inc.: Total Revenue, By Segment, 2011–2013 ($Million)
Table 108 Medtronic: Total Revenue, By Segment, 2011–2013 ($Million)

The bottom-up approach was implemented for arriving at the overall market size of the interventional cardiology and peripheral vascular devices market, based on the individual techniques of interventional cardiology procedures. Calculations based on percentage shares of different techniques, various devices used in individual procedures, and the average selling prices of devices in the U.S. and Canadian markets led to the market size of individual devices. The overall North American interventional cardiology and peripheral vascular devices market was arrived at by summing up the market size of different diagnostic and therapeutic devices in the U.S. and Canada.

The global interventional cardiology and peripheral vascular devices market was used in the top-down approach to estimate the market size for individual devices in North America using percentage splits based on various assumptions derived from secondary and primary research. For the calculation of each market segment, the most appropriate immediate parent market size was used for implementing the top-down approach. The values of the overall parent market and individual segments were arrived at by data triangulation and validation of data through expert interviews.

The following figure shows the forecast model applied in making this report on the North American interventional cardiology and peripheral vascular devices market.

The retrievable IVC filters market is one of the fastest-growing device markets in the U.S. and has been considered as the gold standard for deep vein thrombosis (DVT) treatment. The market size of retrievable IVC filters, in terms of value, was estimated at $XX million in 2013 and is expected to reach $XX million by 2018, at a CAGR of XX% during the forecast period. Among the various types of angiography catheters, the intravascular ultrasound and optical coherence tomography catheter markets are poised to grow at CAGRs of XX% and XX%, respectively.

Market segmentation

The North American interventional cardiology and peripheral vascular devices market is further categorized into angioplasty balloons, angioplasty stents, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and accessory devices. The angioplasty balloons market is subcategorized into old/normal balloons and cutting balloons, whereas the angioplasty stents market is subsegmented into bare-metal stents, drug-eluting stents, and bioabsorbable stents. The catheter market includes both therapeutic devices (guiding catheters) and diagnostic devices (angioplasty catheters, intravascular ultrasounds, and optical coherence tomography catheters).

Market dynamics

Significant growth in peripheral interventional procedures in the U.S. is expected to offset the declining trend in coronary angioplasty procedures in North America. As per the U.S. National Library of Medicine estimates, the incidence rate of peripheral interventional procedures increased from XX to XX per XX population from 1996 to 2006; while, around XX Canadians suffered from peripheral artery disease (PAD) in 2012 and around XX% of PAD patient population opted for endovascular treatment, according to the Canadian Agency for Drugs and Technologies in Health. A nationwide inpatient study, conducted by the American Heart Association (AHA), identified that peripheral interventional procedures accounted for XX% of all hospitalizations in the U.S, in 2011. This study also found that the adoption of endovascular procedures for the treatment of peripheral artery disease increased by XX% in the U.S. from 1996 to 2006. Although, the Canadian peripheral interventional procedures market is not expected to witness such a significant growth, the market is anticipated to witness a CAGR of around XX% during the forecast period. Increasing applications of peripheral devices is expected to spur market growth.

Double digit growth in the aged XX and above’ population is the most promising factor driving the North American interventional cardiology and peripheral vascular devices market. As per the Department of Health & Human Services’ census, the total population aged XX and above was recorded to be XX million in 2000 and the projected range of Y-o-Y growth rate was estimated between XX% and XX% during the forecast period (2013–2018). On the other hand, according to the Statistics Canada, the population aged XX and above was recorded to be XX million in 2012. The aged population accounted for XX% of the total Canadian population in 2012 compared to XX% in 1982. Such significant growth in the aging population is expected to fuel the interventional cardiology procedure market since age is considered as an important factor for the deterioration of cardiac health.



More Publications